Private limited company · Fredrikstad
PHARMATECH AS
ActiveManufacture of homogenised food preparations and dietetic food (10.860)
The life line 2002–2026
Operating revenue per year, with recorded events above. As a table
Operating revenue 2025: NOK 505.7m.
- Founded§ 16
Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.
In brief
PHARMATECH AS is a private limited company in Fredrikstad, founded in 2002, in the industry manufacture of homogenised food preparations and dietetic food. The chief executive is Geir Lund, and the chair of the board is Geir Lund. In 2025 the company had NOK 505.7m in operating revenue and a net profit of NOK 28.2m. The largest owner is GME LUND HOLDING AS with 100.0%.
Put together by Intelligo from the sections below; each figure stands with its source where it belongs.
Overview
§ 01 Latest changes
4 changes, latest 16 Nov 2026
- Job advertisement: Produksjonsoperatør til Pharmatech på Rolvsøy
- Number of employees 163 → 164
- Number of employees 155 → 163
- Number of employees 157 → 155
Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →
Overview
§ 02 Worth knowing
None registered
None of the rules apply.The rules are fixed: bankruptcy, missing annual accounts, three years of losses, negative equity and the like. Checked 15 Nov 2026.
Overview
§ 03 Key figures
Revenue NOK 505.7m in 2025
Revenue
NOK 505.7m
+19.0% from 2024
20232025
Operating profit
NOK 33.0m
+44.3% from 2024
20232025
Net profit
NOK 28.2m
+54.1% from 2024
20232025
Equity
NOK 51.0m
+58.5% from 2024
20232025
Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →
Finances
§ 04 Where the money comes from and goes
Financial year 2025
Of every krone of operating revenue in 2025:
- Wages and social costs 17%
- Depreciation 1%
- Other operating costs 8%
- Not specified in the source 67%
- Left as operating result 7%
Of the net profit for 2025, NOK 18.8m stayed in the company. The rest, NOK 9.4m, is an assumed dividend.
The assumed dividend is derived by Intelligo from the change in equity, not stated by the source. Source: the Register of Company Accounts via areg.no, read 15 Nov 2026
Finances
§ 05 Financial health
Equity ratio 33.2%
- PHARMATECH AS, 2025
- Industry median, assumed: NOK 7.2m · 3.0% · 34.5% · +7.5%
Equity NOK 51.0m33% of the assets (NOK 153.5m)
Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 1,759 companies in industry division 10 (Manufacture of food products), not stated by the source.
Finances
§ 06 Accounts
24 years, latest 2025
| NOK 1,000 | 2023–25 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating revenue | 505,693 | 424,982 | 404,181 | |
| Operating profit | 33,040 | 22,897 | 12,896 | |
| Profit before tax | 36,255 | 23,503 | 7,875 | |
| Net profit | 28,248 | 18,325 | 6,337 | |
| Total assets | 153,483 | 125,477 | 121,756 | |
| Equity | 51,016 | 32,188 | 21,363 | |
| Liabilities | 102,467 | 93,289 | 100,393 |
Source: the Register of Company Accounts, read 15 Nov 2026 · All 24 years →
Management and ownership
§ 07 Officers
4 officers now
- Geir LundChief executive
- Geir LundChair of the board
- BDO ASAuditor
- Mette Kristin LundDeputy board member
Source: the Brønnøysund Register Centre, read 23 Oct 2026 · All 4 roles, former ones too →
Management and ownership
§ 08 Signature, procuration and authorisations
Styrets medlemmer hver for seg eller daglig leder alene.
May sign for the company:
Styrets medlemmer hver for seg eller daglig leder alene.
Power of procuration:
Daglig leder og styrets leder hver for seg.
The signature is word for word from the register. Source: the Register of Business Enterprises, read 24 Aug 2026
Management and ownership
§ 09 Owners
1 shareholder · largest 100.0%
| Owner | Share |
|---|---|
| GME LUND HOLDING AS | 100.0% |
Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 1 owners →
Management and ownership
§ 10 Group
None registered
Not a group.No subsidiaries in the shareholder register, and no group accounts. Checked 15 Nov 2026.
Management and ownership
§ 11 Portfolio
None registered
No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.
Management and ownership
§ 12 Network
30 connections
- Person
- Company
2 people link PHARMATECH AS to 12 other companies: Geir Lund 12 and Mette Kristin Lund 9.
Source: the Brønnøysund Register Centre, read 23 Oct 2026 · Explore the network →
Events and registers
§ 13 Events
9 since 2015
Events per year
20152026
Since 2015: 2 announcements, 7 register changes and 1 job advertisement. Most happened in 2023 and 2026.
Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 15 Nov 2026. Register changes are Intelligo's own observations. · All 9 events →
Events and registers
§ 14 Notices
2, latest 10 Aug 2023
- Godkjente årsregnskap
- Nyregistrering i Foretaksregisteret
Source: The Brønnøysund Register Centre's announcements ↗, read 15 Nov 2026 · All 2 →
Events and registers
§ 15 Charges
Not fetched yet
Events and registers
§ 16 Other registers
Found in 3 of 7
- The Central Coordinating RegisterRegistered 6 Apr 2002
- VATRegistered
- The Register of Business EnterprisesRegistered 6 Apr 2002
- The Cleaning RegisterNot registered
- The Register of Staffing AgenciesNot registered
- Smiley scheme, the Norwegian Food Safety AuthorityNot registered
- The Financial Supervisory Authority's licence registerNot registered
Purpose: Produksjon av legemidler og farmasøytiske produkter.
Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026
Market
§ 17 Tenders
None registered
No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.
Market
§ 18 Vacancies
1 vacancy
- Produksjonsoperatør til Pharmatech på Rolvsøy FredrikstadDeadline 7 Dec 2026
Source: NAV Arbeidsplassen, fetched 17 Nov 2026
Market
§ 19 Competitors
Industry code 10.860
The companies most like it:
Compare themThe selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →
Last
§ 20 Questions and answers
8 questions
- Who is the chief executive of PHARMATECH AS?
Geir Lund. § 07 - Who owns PHARMATECH AS?
1 shareholder. It is GME LUND HOLDING AS with 100.0%. § 09 - What was the revenue in 2025?
NOK 505.7m in the company. § 06 - Who can sign for PHARMATECH AS?
Styrets medlemmer hver for seg eller daglig leder alene. § 08 - Who is the auditor?
BDO AS. § 07 - Does PHARMATECH AS have vacancies?
Yes, 1 advertised at NAV as of 17 Nov 2026: Produksjonsoperatør til Pharmatech på Rolvsøy . § 18 - Where is PHARMATECH AS based?
Vallehellene 4, 1664 Rolvsøy. - When was PHARMATECH AS founded?
1 Mar 2002, registered in the Register of Business Enterprises 6 Apr 2002. § 16
The answers come from the sections linked to, with their sources.